Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting, 65861 [E8-26336]

Download as PDF Federal Register / Vol. 73, No. 215 / Wednesday, November 5, 2008 / Notices review/public/ using the docket numbers listed in this notice. Dated: October 27, 2008. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E8–26359 Filed 11–4–08; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Office of the Director (OD)/Office of the Chief of Public Health Practice (OCPHP)/Office of Minority Health and Health Disparities (OMHD) hsrobinson on PROD1PC76 with NOTICES In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of September 23, 2004, Consultation and Coordination with Indian Tribal Governments, the Centers for Disease Control (CDC) OD/OSI/ OMHD announces the following meeting and Tribal Consultation Session: Name: Tribal Consultation Advisory Committee (TCAC) Meeting and the Biannual Tribal Consultation Session. Times and Dates: TCAC Meeting on November 18–19, 2008 from 8 a.m.–5:30 p.m. and the Biannual Tribal Consultation Session on February 28, 2009 from 8–6 p.m. Place: Hosted by Tohono O’odham Nation at the Desert Diamond Casino & Hotel, 7350 S. Nogales Highway, Tucson, Arizona 85706, Telephone: 1–877–777–4212. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 80 people. Purpose: CDC established their Tribal Consultation Policy in October of 2005 with the primary purpose of providing guidance across the agency to work effectively with American Indian/Alaska Native (AI/AN) tribes, communities, and organizations to enhance AI/AN access to CDC programs. In October of 2005, an Agency Advisory Committee (CDC/ATSDR Tribal Consultation Advisory Committee—TCAC) was established to provide a complementary venue wherein tribal representatives and CDC staff will exchange information about public health issues in Indian Country, identifying urgent public health issues in Indian Country, and discuss collaborative approaches to these issues. Within the CDC Consultation Policy, it is stated that CDC will conduct government-to-government consultation with elected tribal officials or their designated representatives and also confer with tribal and Alaska Native organizations and AI/AN urban and rural communities before taking actions and/or making decisions that affect them. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an VerDate Aug<31>2005 17:24 Nov 04, 2008 Jkt 217001 open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. CDC believes that consultation is integral to a deliberative process that results in effective collaboration and informed decision making with the ultimate goal of reaching consensus on issues. Although formal responsibility for the agency’s overall government-togovernment consultation activities rests within the Office of the Director, Coordinating Centers, Coordinating Offices, and center leadership shall actively participate in TCAC meetings, and HHSsponsored regional, and national tribal consultation sessions as frequently as possible. Matters To Be Discussed: The TCAC will convene their quarterly committee meeting with discussions and presentations from various CDC senior leadership on activities and areas identified by tribal leaders as priority public health issues. The Biannual Tribal Consultation Session will engage CDC Senior leadership from the Office of the Director and various CDC Offices and National Centers including the Financial Management Office (FMO), National Center for Environmental Health and the Agency for Toxic Substances (NCEH/ATSDR), Coordinating Office for Terrorism and Preparedness and Emergency Response (COTPER), National Center for Health Marketing (NCHM), the Office of Chief of Public Health Practice, and the Office of Enterprise Communications (OEC). Opportunities will be provided during the Consultation Session for tribal testimony. Tribal Leaders are encouraged to submit written testimony by close of business on November 7, 2008 to Capt. Pelagie (Mike) Snesrud, Senior Tribal Liaison for Policy and Evaluation, Office of Minority Health and Health Disparities, 1600 Clifton Road, NE., Mailstop E–67, Atlanta, GA 30333, telephone (404)498–2343, fax (404)498–2355, e-mail: pws8@cdc.gov. Depending on the time available it may be necessary to limit the time of each presenter. Please reference the Web link of http://www.cdc.gov/omhd/TCAC/AAC.html to review information about the TCAC and CDC’s Tribal Consultation Policy. For Further Information Contact: Capt. Pelagie (Mike) Snesrud, Senior Tribal Liaison for Policy and Evaluation, Office of Minority Health and Health Disparities, 1600 Clifton Road, NE., Mailstop E–67, Atlanta, GA 30333, telephone (404)498–2343, fax (404)498–2355, e-mail: pws8@cdc.gov. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel. Pharmacological approaches to KNa channels and the FMRP signaling pathway. Date: December 5, 2008. Time: 1 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852. (Telephone Conference Call) Contact Person: Anne Krey, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 301–435– 6908. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 29, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–26336 Filed 11–4–08; 8:45 am] BILLING CODE 4140–01–P Dated: October 27, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–26292 Filed 11–4–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 65861 E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 73, Number 215 (Wednesday, November 5, 2008)]
[Notices]
[Page 65861]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26336]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel. Pharmacological approaches to 
KNa channels and the FMRP signaling pathway.
    Date: December 5, 2008.
    Time: 1 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Room 5B01, Rockville, MD 20852. (Telephone Conference Call)
    Contact Person: Anne Krey, PhD, Scientific Review Administrator, 
Division of Scientific Review, National Institute of Child Health 
and Human Development, National Institutes of Health, Bethesda, MD 
20892, 301-435-6908.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: October 29, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-26336 Filed 11-4-08; 8:45 am]
BILLING CODE 4140-01-P